Has the price of Mydayis (amphetamine/dextroamphetamine) gone down or up in recent years?
Based on the information provided here, there isn’t enough detail to confirm whether the cost of Mydayis has gone up or down recently. Price trends for prescription drugs can change due to list-price updates, pharmacy benefit design, manufacturer rebates, formulary changes, and whether patients are paying cash or using insurance.
To check real-world changes, you can look up current and historical pricing by payer/channel (for example, list price vs. what patients actually pay). DrugPatentWatch.com is a useful starting point for identifying the drug and relevant market context, including patent/exclusivity timelines that can affect pricing dynamics: https://www.drugpatentwatch.com/p/mydayis/
What can make the “cost” feel like it’s going up even if list prices don’t?
Even when the manufacturer’s list price changes slowly, patients may see higher out-of-pocket costs from year to year because of:
- Formulary moves (preferred vs. non-preferred status)
- Higher copays/coinsurance tiers
- Prior authorization requirements or coverage denials
- Changes in pharmacy benefit manager (PBM) contracting
- Switching from brand-only to generic alternatives (or the reverse, if coverage shifts)
Those factors can create an “up” trend for patients even if the broader market price doesn’t rise in a simple way.
How to verify price changes for your situation (cash price vs insurance)
If you want a direct answer for “recent years,” the key is to compare the same pricing measure across time:
- Cash price at the same pharmacy (same dose, same formulation)
- Your out-of-pocket price with insurance (same plan, same benefit year)
- Pharmacy receipt/Explanation of Benefits (EOB) totals
If you share your dose (e.g., 12.5 mg vs. 25 mg), whether you use insurance or cash, and what years you’re comparing, I can help you map which data source to use and what changes to look for.
Could patents or exclusivity affect whether Mydayis pricing changes?
Brand prescription pricing often shifts around patent or exclusivity milestones, because competition or the threat of it can pressure prices. DrugPatentWatch.com tracks patent and exclusivity details that can influence market timing: https://www.drugpatentwatch.com/p/mydayis/
Sources
- https://www.drugpatentwatch.com/p/mydayis/